Navigation Links
Watson Receives Final Approval of Omeprazole Delayed-Release Capsules
Date:6/3/2008

CORONA, Calif., June 2 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that it has received final approval from the U.S. Food and Drug Administration ("FDA") of its Abbreviated New Drug Application (ANDA) for Omeprazole Delayed-Release Capsules USP in the 10mg, 20mg and 40mg strengths.

Watson has been awarded 180 days of marketing exclusivity for being the first to file an ANDA containing a paragraph IV certification for the 40mg strength. Watson's marketing exclusivity will begin upon commercial launch. The Company plans to launch its Omeprazole Delayed-Release product during the third quarter of 2008. The specific launch date will depend upon the timing of product validation activities and manufacturing of launch quantities. Watson plans to launch only the 40 mg strength.

Omeprazole is the generic equivalent to AstraZeneca's Prilosec(R) Delayed-Release Capsules USP and is indicated for the short-term treatment of active duodenal ulcer. For the 12-months ending March 2008, Prilosec(R) Delayed-Release Capsules and its generic equivalents had total U.S. sales of approximately $240 million, according to IMS Health.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc., headquartered in Corona, CA, is a leading specialty pharmaceutical company that develops, manufactures, markets, sells and distributes brand and generic pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses.

For press releases and other company information, visit Watson Pharmaceuticals' Web site at

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Watson Receives FDA Approval of Potassium Chloride Extended-Release Capsules
2. Watson Announces Oxybutynin Topical Gel NDA Accepted for Filing by FDA for the Treatment of Overactive Bladder
3. Watson to Present at the UBS Global Specialty and Generic Pharmaceuticals Conference
4. Watson to Present at the Bank of America 2008 Healthcare Conference
5. Texas Senator Kirk Watson Honored as Champion for Children by the AMERIGROUP Foundation
6. Watson Files Application for Generic SEASONIQUE(R)
7. 60 Minutes to Report on Dangers of Trasylol: Cory Watson Crowder & DeGaris Involved in Litigation Against Pharmaceutical Giant Bayer AG
8. Few Employers Addressing Workplace Stress, Watson Wyatt Surveys Find
9. Watson Pharmaceuticals Announces FDA Inspection of Florida Facilities
10. Medical Cost Increases to Accelerate Worldwide Over Next Five Years, Watson Wyatt Poll Finds
11. Watson to Distribute Alendronate Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... ... Dignity Health named Dr. Norris A. Baldwin, Jr. the Facility Medical Director ... August. The new facility is licensed under Dignity Health Arizona General Hospital ... is an excellent leader and will ensure our new freestanding emergency room delivers the ...
(Date:8/3/2015)... , ... August 03, 2015 , ... Constantin Vasilica, 48 ... by tissue injury caused by diabetes after many years of suffering and using medications ... and he didn’t want to ask for extra time off or wait longer hours ...
(Date:8/3/2015)... ... August 03, 2015 , ... Foot and Ankle Specialists of the ... creating the largest medical practice in the Mid-Atlantic region – and the second largest ... locations with 33 doctors. , Dr. Hetal Kathrotiya-Mago is a Maryland native. She grew ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... Code Council (ICC) announce an agreement to collaborate across a wide range ... to increasing building code knowledge among architects. , “Our combined membership, consisting of ...
(Date:8/3/2015)... ... 03, 2015 , ... Recent reports by the American Medical Association show that ... their lives. Often time, low back and sciatic pain can happen as a result ... clinically with powerful pain medication or spinal surgery. Dynamic Health Care in Louisville, ...
Breaking Medicine News(10 mins):Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 2Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 3Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 3Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 2Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 3Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 4Health News:Architects, International Code Council Ink Five-Year Collaborative Agreement 2Health News:Architects, International Code Council Ink Five-Year Collaborative Agreement 3Health News:Dynamic Health Care in Louisville, KY, Offers a New and Cutting-Edge Therapy for Low Back & Leg Pain Sufferers 2
... with diabetes are sexually active according to a study of ... September 2010 issue of the journal Diabetes Care . ... percent of partnered women with diabetes engaged in sexual activity ... diabetes, the study showed. The disease took a toll, ...
... difficile, a wily, familiar bacterium, causes a growing number ... a $7.5 million, five-year award from the National Institutes of ... in the microbe and in patients make C. difficile ... nearly a half-million Americans each year. ,U-M scientists and clinicians ...
... stay sober for several decades. It interferes with the body,s ... who consumes even a small amount of alcohol. More ... addiction as well, even though alcohol and cocaine affect the ... Emory University School of Medicine have identified how disulfiram may ...
... a small and cheap-to-build unmanned aerial vehicle (UAV) intended ... reduce risks to material and human lives. The seaplane ... plane to fly in severe weather conditions. The resulting ... payload of up to 40 kg. It is equipped ...
... Jenifer Goodwin HealthDay Reporter , WEDNESDAY, Aug. 25 ... the economic recession in 2008, nearly one in four American ... inadequate they were unable to access the medical care their ... special needs were more likely than others to say their ...
... may potentially play an important role in treating ... disabling diseasethe Society of Interventional Radiology has issued ... clinical research to determine the safety and effectiveness ... endorsed by the Canadian Interventional Radiology Association and ...
Cached Medicine News:Health News:Diabetes impairs but does not halt sex among older adults 2Health News:Diabetes impairs but does not halt sex among older adults 3Health News:U-M launches effort to conquer common hospital-acquired infection 2Health News:Experimental treatments for cocaine addiction may prevent relapse 2Health News:Shape-shifting robot plane offers safer alternative for maritime rescue 2Health News:Shape-shifting robot plane offers safer alternative for maritime rescue 3Health News:Even Before Recession, 14 Million Kids 'Underinsured': Study 2Health News:Even Before Recession, 14 Million Kids 'Underinsured': Study 3Health News:Society of Interventional Radiology supports research for new MS treatments 2Health News:Society of Interventional Radiology supports research for new MS treatments 3
(Date:8/3/2015)... -- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK ) today announced ... Investor Conference Call and webcast at 4:30 p.m., Eastern time, ... cover an update on Merrimack,s progress as well as ... release detailing the information to be discussed on the ... 10. Investors and the general public are invited to ...
(Date:8/3/2015)... PARK, N.J. , Aug. 3, 2015 ... and secondary endpoints in a phase III study (COMPOSE ... adult patients with chronic non-cancer pain. Naldemedine is an ... is the third Phase III trial in which naldemedine ... Study results showed that a 0.2 mg tablet of ...
(Date:8/3/2015)... LEXINGTON, Massachusetts , August 3, 2015 /PRNewswire/ ... SHPG ) announced today that it has ... held Foresight Biotherapeutics Inc. for $300 million. With ... FST-100 (topical ophthalmic drops combining 0.6% povidone iodine ... development for the treatment of infectious conjunctivitis, an ...
Breaking Medicine Technology:Merrimack Pharmaceuticals Announces Timing of Second Quarter 2015 Investor Conference Call 2Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 4Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 2Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 3Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 4Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 5Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 6
... Nov. 29 Dr. Christine Cassel,expert and author ... has,been named a member of the Alzheimer,s Study ... former Speaker of the House Newt Gingrich and,former ... President and Chief Executive Officer of the American,Board ...
... Getty Images, ,Change Me, Initiative Raised Worldwide Awareness and Funds ... to Fight Aids, Tuberculosis and ... the world,s leading imagery creator and distributor, today announced,the successful ... used powerful images to share their thoughts on how to ...
Cached Medicine Technology:American Board of Internal Medicine President Named to Alzheimer's Study Group 2Getty Images Celebrates Conclusion of 'Change Me' Imagery Forum 2Getty Images Celebrates Conclusion of 'Change Me' Imagery Forum 3
... is a simple, effective instrument to grasp soft ... stitch and loop. The grasping function of the ... tissue and precisely place a stitch up to ... tissue, all in one quick step. The sterile, ...
... The patented ratchet design provides fingertip ... ,The Series I Instrument program offers state-of-the-art ... profile, while maintaining strength and durability. Low ... in tight joint spaces. Series I instruments ...
Leg holder for arthroscopy....
Irrigation pump for arthroscopy....
Medicine Products: